Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Yidu TechSTU:0EL -1.20%43 Return-on-Tangible-Equity is 4.80% as of Mar. 2026. GuruFocus rates STU:0EL with a GF Score™ of 43/100 and a GF Value™ of €0.66 (Modestly Undervalued). The stock has 7 warning signs investors should review. Among 578 Healthcare Providers & Services companies, Yidu Tech ranks worse than 72.15% on this metric.
Return-on-Tangible-Equity is calculated as Net Income divided by its average total shareholder tangible equity. Total shareholder tangible equity equals to Total Stockholders Equity minus Intangible Assets. Yidu Tech's annualized net income for the quarter that ended in Mar. 2026 was €21.9 Mil. Yidu Tech's average shareholder tangible equity for the quarter that ended in Mar. 2026 was €456.2 Mil. Therefore, Yidu Tech's annualized Return-on-Tangible-Equity for the quarter that ended in Mar. 2026 was 4.80%.
The historical rank and industry rank for Yidu Tech's Return-on-Tangible-Equity or its related term are showing as below:
STU:0EL'
s Return-on-Tangible-Equity Range Over the Past 10 Years
Min: -617.19 Med: -9.92 Max: 2
Current: 2
During the past 9 years, Yidu Tech's highest Return-on-Tangible-Equity was 2.00%. The lowest was -617.19%. And the median was -9.92%.
STU:0EL's Return-on-Tangible-Equity is ranked worse than 72.15% of 578
companies
in the Healthcare Providers & Services industry
Industry Median: 10.635
vs STU:0EL: 2.00
Return-on-Tangible-Equity measures the rate of return on the ownership interest (shareholder's tangible equity) of the common stock owners. It measures a firm's efficiency at generating profits from every unit of shareholders' tangible equity (shareholders equity minus intangibles). Return-on-Tangible-Equity shows how well a company uses investment funds to generate earnings growth. Return-on-Tangible-Equitys between 15% and 20% are considered desirable.
Be Aware
Net Income is used.
Because a company can increase its Return-on-Tangible-Equity by having more financial leverage, it is important to watch the leverage ratio when investing in high Return-on-Tangible-Equity companies. Like Return-on-Tangible-Asset, Return-on-Tangible-Equity is calculated with only 12 months data. Fluctuations in company's earnings or business cycles can affect the ratio drastically. It is important to look at the ratio from a long term perspective.
Asset light businesses require very few assets to generate very high earnings. Their Return-on-Tangible-Equitys can be extremely high.
Yidu Tech Return-on-Tangible-Equity Related Terms
Yidu Tech Return-on-Tangible-Equity Historical Data
* Premium members only.
The historical data trend for Yidu Tech's Return-on-Tangible-Equity can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
STU:0EL vs VEEV, BTSG, HQY: Return-on-Tangible-Equity Comparison
For the Health Information Services subindustry, Yidu Tech's Return-on-Tangible-Equity, along with its competitors' market caps and Return-on-Tangible-Equity data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Yidu Tech Return-on-Tangible-Equity vs Healthcare Providers & Services Industry
For the Healthcare Providers & Services industry and Healthcare sector, Yidu Tech's Return-on-Tangible-Equity distribution charts can be found below:
* The bar in red indicates where Yidu Tech's Return-on-Tangible-Equity falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
In the calculation of annual Return-on-Tangible-Equity, the net income of the last fiscal year and the average total shareholder tangible equity over the fiscal year are used. In calculating the quarterly data,
the net income data used here is two times the semi-annual (Mar. 2026) net income data.
Return-on-Tangible-Equity is displayed in the 10-year financial page.
What does a Return-on-Tangible-Equity of 4.80% mean?
Yidu Tech (STU:0EL) has a Return-on-Tangible-Equity of 4.80% as of Mar. 2026. Return on tangible equity is the ratio of current-period net income to average two-period tangible equity. View historical data on Yidu Tech and its competitors. According to the industry distribution chart, Yidu Tech ranks #417 out of 578 companies in the Healthcare Providers & Services industry, placing it in the top 72.1%.
Is Yidu Tech's Return-on-Tangible-Equity too high?
Yidu Tech's current Return-on-Tangible-Equity is 4.80%. The Healthcare Providers & Services industry median Return-on-Tangible-Equity is 10.64. Yidu Tech's value of 4.80% is 54.9% below this industry median. Based on the distribution chart, Yidu Tech ranks #417 out of 578 companies in the Healthcare Providers & Services industry, which is below the industry midpoint. Overall, Yidu Tech has a GF Score™ of 43/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Yidu Tech's Return-on-Tangible-Equity compare to VEEV and BTSG?
According to the Healthcare Providers & Services industry distribution chart, Yidu Tech ranks #417 out of 578 companies for Return-on-Tangible-Equity. This places Yidu Tech in the lower half of its industry. The industry median Return-on-Tangible-Equity is 10.64. Yidu Tech's value of 4.80% is 54.9% below this benchmark. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Return-on-Tangible-Equity for a Healthcare Providers & Services company?
The median Return-on-Tangible-Equity among Healthcare Providers & Services companies is 10.64, based on 578 companies in the industry. Companies in the top quartile (top 25%) have a Return-on-Tangible-Equity significantly above this median, while those in the bottom quartile fall well below. However, Return-on-Tangible-Equity should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Yidu Tech's current Return-on-Tangible-Equity of 4.80% is 54.9% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Return-on-Tangible-Equity mean?
A high Return-on-Tangible-Equity can signal that a stock is expensive relative to its fundamentals. Return on tangible equity is the ratio of current-period net income to average two-period tangible equity. View historical data on Yidu Tech and its competitors. For the Healthcare Providers & Services industry, the median Return-on-Tangible-Equity is 10.64 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Yidu Tech's current Return-on-Tangible-Equity is 4.80%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Yidu Tech stock overvalued right now?
Based on GuruFocus' analysis, Yidu Tech (STU:0EL) is currently considered Modestly Undervalued. The stock's GF Value™ is €0.66, compared to a current price of €0.49 — trading 25.2% below its estimated fair value. The current Return-on-Tangible-Equity is 4.80% and 54.9% below the Healthcare Providers & Services industry median of 10.64. Yidu Tech's overall GF Score™ is 43/100 with 7 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Return-on-Tangible-Equity calculated?
Return-on-Tangible-Equity is calculated from a company's financial statements. For Yidu Tech (STU:0EL), the current Return-on-Tangible-Equity is 4.80% as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Yidu Tech (STU:0EL) Overvalued in 2026?
Based on GuruFocus' analysis, Yidu Tech stock appears to be undervalued.
The current stock price of €0.49 is trading 25.2% below its estimated GF Value™ of €0.66.
GuruFocus considers Yidu Tech to be Modestly Undervalued.
Key valuation signals for STU:0EL:
Return-on-Tangible-Equity: 4.80%
GF Value™: €0.66 vs. price of €0.49 (25.2% below fair value)
Industry Position: 54.9% below the Healthcare Providers & Services median (#417 of 578)
No single metric tells the full story. See the STU:0EL stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Yidu Tech Inc offers healthcare solutions built on big data and artificial intelligence (AI) technologies. The company serves various healthcare industry participants, including hospitals, pharmaceutical, biotech, research institutions, insurance companies, etc. Its operating segments are: Big data platform and solutions, Life sciences solutions, and Health management platform and solutions. The majority of the company's revenue is generated from its Big data platform and solutions segment, which provides data intelligence platforms and data analytics-driven solutions (such as Eywa 5.0, Lingxi Intelligent Management, AI Middleware, etc.) for hospitals, healthcare institutions, regulators, and policymakers. Geographically, the company generates maximum revenue from Mainland China.
43GF Score
Get the complete analysis for STU:0EL
Return-on-Tangible-Equity is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
STU:0EL has been successfully added to your 
